Cardiovascular outcomes of type 2 diabetic patients treated with DPP-4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice. (2021)

First Author: Bazo-Alvarez JC

Attributed to: Method - Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-021-02670-9

PubMed Identifier: 34903733

Publication URI: http://europepmc.org/abstract/MED/34903733

Type: Journal Article/Review

Volume: 11

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322